Mark Guerin
Director of Finance/CFO presso TRAWS PHARMA, INC.
Patrimonio netto: 36 336 $ in data 31/03/2024
Profilo
Mark P.
Guerin is currently the Chief Financial Officer at Traws Pharma, Inc. He previously worked as the Director of Financial Reporting & Internal Controls at Barrier Therapeutics, Inc. and as the Chief Financial Officer & Vice President of Finance at CardioKine, Inc. Mr. Guerin obtained his undergraduate degree from DeSales University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
TRAWS PHARMA, INC.
0.17% | 14/03/2024 | 35 976 ( 0.17% ) | 36 336 $ | 31/03/2024 |
Posizioni attive di Mark Guerin
| Società | Posizione | Inizio |
|---|---|---|
| TRAWS PHARMA, INC. | Director of Finance/CFO | 12/02/2016 |
Precedenti posizioni note di Mark Guerin
| Società | Posizione | Fine |
|---|---|---|
CardioKine, Inc.
 CardioKine, Inc. Pharmaceuticals: MajorHealth Technology CardioKine, Inc. develops drugs and pharmaceuticals for the treatment and prevention of heart failure. The company was founded by Arthur Michael Feldman, James Mervis, Paul-Andre de Lame and Michael Juliano in 2004 and is headquartered in Pittsburgh, PA. | Director of Finance/CFO | 01/12/2011 |
Barrier Therapeutics, Inc.
 Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | Corporate Officer/Principal | - |
Formazione di Mark Guerin
| DeSales University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| TRAWS PHARMA, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Barrier Therapeutics, Inc.
Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | Health Technology |
CardioKine, Inc.
CardioKine, Inc. Pharmaceuticals: MajorHealth Technology CardioKine, Inc. develops drugs and pharmaceuticals for the treatment and prevention of heart failure. The company was founded by Arthur Michael Feldman, James Mervis, Paul-Andre de Lame and Michael Juliano in 2004 and is headquartered in Pittsburgh, PA. | Health Technology |
- Borsa valori
- Insiders
- Mark Guerin
